Loading…
Loading…
The Convergence Long/Short Equity ETF seeks to provide a greater return potential than traditional approaches while reducing risk. The fund endeavors to provide a material and consistent alpha through its proprietary fundamental ranking process from both long and short holdings over a market cycle.
Is CLSE's expense ratio expensive, average, or a steal for its category?
Pro reveals the verdict on a 5-tier spectrum calibrated against ICI 2025 industry averages, with strategy-aware bands so the comparison is meaningful.
Advisors did not slow down on exchange-traded funds in the second quarter. They added more of them, and pointed the money somewhere new, according to AdvizorPro's Q2 2026 RIA ETF Trends report.
The Convergence Long/Short Equity ETF (CLSE) combines quantitative and fundamental factors to run long and short positions across roughly 3,000 US equities. The fund's short book carries a much higher P/E and beta than its long book, targeting expensive, weaker names. CLSE has outperformed peers like FTLS, ORR and HFEQ on a risk-adjusted basis over the past five years.
Convergence Long/Short Equity ETF has an active strategy designed to deliver “alpha from a net long portfolio.”. I maintain a Buy rating on CLSE, supported by its over 11% outperformance since the February note that proves the high adaptability of the strategy. Since conversion into an ETF, CLSE has delivered an annualized active return of 7.15% (with IWV selected as a benchmark), with a lower standard deviation.
New AdvizorPro data shows RIAs broadened their ETF lineups in Q1 2026, leaning into real assets, active managers, and defense strategies.
The Convergence Long/Short Equity ETF has delivered additional proof of tail risk mitigation without surrendering much upside capture this year. Modest drawdowns were experienced during March's sell-off, and index-level upside capture occurred in April. The vehicle's long exposure is currently at ~60%, its lower bound, and management communicated alignment in favour of value over momentum and broadening over narrowing post Q1.